Solvay To Co-Promote Wyeth’s Effexor XR With 120 Reps
Under the agreement, Wyeth will co-develop four mental health products from Solvay’s pipeline, including bifeprunox, an atypical antipsychotic in Phase III.
Under the agreement, Wyeth will co-develop four mental health products from Solvay’s pipeline, including bifeprunox, an atypical antipsychotic in Phase III.